Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.11% |
| 2 | Healthcare | 13.18% |
| 3 | Financials | 12.45% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Communication Services | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Mustang Bio
MBIO
$4.59M
| $776K | ﹤0.01% |
312
+69
| +28% | +$169K |
|
|
TARO
3502
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $776K | ﹤0.01% |
10,782
-378
| -3% | -$27.8K |
|
3503
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.85B
| $775K | ﹤0.01% |
8,198
+210
| +3% | +$19.6K |
|
3504
Viemed Healthcare
VMD
$353M
| $772K | ﹤0.01% |
107,971
+13,967
| +15% | +$121K |
|
3505
Immunic
IMUX
$217M
| $771K | ﹤0.01% |
6,283
+2,200
| +54% | +$304K |
|
3506
Western New England Bancorp
WNEB
$282M
| $771K | ﹤0.01% |
94,604
-71,661
| -43% | -$592K |
|
|
RXDX
3507
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $771K | ﹤0.01% |
+31,404
| New | +$701K |
|
3508
Viant Technology
DSP
$264M
| $770K | ﹤0.01% |
25,832
-2,802
| -10% | -$90.1K |
|
3509
First Bank
FRBA
$471M
| $770K | ﹤0.01% |
56,859
-9,524
| -14% | -$123K |
|
|
BCEL
3510
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $768K | ﹤0.01% |
90,241
-16,201
| -15% | -$166K |
|
|
PROS
3511
DELISTED
ProSight Global, Inc.
PROS
| $767K | ﹤0.01% |
60,121
-4,315
| -7% | -$55K |
|
3512
SandRidge Energy
SD
$529M
| $760K | ﹤0.01% |
120,926
+32,039
| +36% | +$161K |
|
|
SUP
3513
DELISTED
Superior Industries International
SUP
| $760K | ﹤0.01% |
88,263
+40,541
| +85% | +$278K |
|
3514
GS ActiveBeta US Small Cap Equity ETF
GSSC
$1.11B
| $755K | ﹤0.01% |
11,614
+1,095
| +10% | +$69.9K |
|
3515
Mistras Group
MG
$556M
| $755K | ﹤0.01% |
76,733
+955
| +1% | +$10.3K |
|
3516
Parke Bancorp
PKBK
$409M
| $753K | ﹤0.01% |
38,464
-27,443
| -42% | -$560K |
|
|
MFNC
3517
DELISTED
Mackinac Financial Corporation
MFNC
| $750K | ﹤0.01% |
37,938
-19,920
| -34% | -$405K |
|
|
FTSI
3518
DELISTED
FTS International, Inc. Common Stock
FTSI
| $750K | ﹤0.01% |
+26,495
| New | +$687K |
|
3519
Bankwell Financial Group
BWFG
$542M
| $737K | ﹤0.01% |
26,687
-18,023
| -40% | -$505K |
|
3520
Eastern Company
EML
$154M
| $737K | ﹤0.01% |
24,330
-13,508
| -36% | -$403K |
|
|
LOTZ
3521
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
| $736K | ﹤0.01% |
134,751
+110,428
| +454% | +$696K |
|
3522
ARK Innovation ETF
ARKK
$6.54B
| $734K | ﹤0.01% |
5,616
-748
| -12% | -$87.2K |
|
3523
iShares US Utilities ETF
IDU
$1.38B
| $728K | ﹤0.01% |
9,272
+1
| +0% | +$81 |
|
3524
Arbutus Biopharma
ABUS
$908M
| $727K | ﹤0.01% |
239,992
+188,576
| +367% | +$584K |
|
3525
Acme United Corp
ACU
$228M
| $725K | ﹤0.01% |
16,277
+34
| +0.2% | +$1.46K |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.